LOS ANGELES, June 21, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 22, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) securities between February 3, 2022 and February 13, 2024, inclusive (the “Class Period”). If you suffered a loss on your Biogen investments or would like to inquire about potentially pursuing claims ...